权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A visible machine learning system to discover targeted treatment solutions in cancer

可见的机器学习系统，用于发现癌症的靶向治疗解决方案

基本信息

批准号：
10784808
负责人：
Yue Qin
金额：
$ 9.3万
依托单位：
BROAD INSTITUTE, INC.
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-03-01 至 2027-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10784808
关键词：
Address Affinity Chromatography Architecture Award Awareness Binding Proteins Biological CRISPR screen Cancer Biology Cancer Patient Cancer cell line Cells Cellular Structures Complex Critical Pathways Data Defect Educational process of instructing Ensure Future Generations Genes Genetic Genetic Engineering Genetic Predisposition to Disease Genome engineering Genomics Genotype Image Immunofluorescence Immunologic Individual Interdisciplinary Study Investigation Knock-out Lead Learning Machine Learning Malignant Neoplasms Maps Mass Spectrum Analysis Mentors Methods Modality Mutation Nature Oral Pathway interactions Phase Phenotype Postdoctoral Fellow Proteins Proteome Research Research Personnel Research Project Grants Resolution Resources System Therapeutic Training Writing cancer cell cancer genome combinatorial data integration deep neural network design empowerment experimental study fitness gene interaction improved insight knockout gene large scale data loss of function mutation machine learning framework metabolome nanometer neural network neural network architecture preservation skill acquisition skills synergism synthetic lethal interaction targeted treatment therapeutically effective therapy design transcriptome tumor

项目摘要

Project Summary/Abstract Understanding of genetic interactions can lead to therapeutic design for individual cancer patients by targeting the specific genetic vulnerability in the cancer genome. For example, by identifying gene pairs that pose severe fitness defects when knocked out simultaneously (compared to separate knockouts), one can selectively kill cancer cells that harbor loss-of-function mutation in one protein by inhibiting its synthetic-lethal partner. Despite generation of large-scale data delineating the tumor transcriptome, proteome, metabolome, imaging, and so on, little is known regarding how different genes interact with each other and it is unclear how one can design targeted treatments based on the ‘omics data available. To address these challenges, the proposed research will develop a “visible” machine learning framework to systematically understand the higher-order genetic interactions (i.e. di-genic and tri-genic interactions) in cancer and design targeted treatments. The first step for the proposed framework is to gain a holistic view of cancer pathways through combining the ‘omics data available. Multiple approaches have been applied to integrate data of similar forms, but there yet lacks an effective solution for integrating data of vastly different qualities and formats. To address this challenge, Yue Qin has developed a method to infer a hierarchical cancer cell map capturing cancer pathways at multi- scale resolution by fusing immunofluorescence (IF) imaging data and affinity purification-mass spectrometry (AP- MS). During the F99 phase of the proposed research, by tying the architecture of a deep neural network to the hierarchical cancer cell map, Yue will develop a “visible” neural network (VNN) that can predict the cancer cell fitness from genetic perturbation (i.e. knockouts) and genomic backgrounds (i.e. mutations) while providing mechanistic insights in cancer pathways critical for genotype-phenotype prediction. During the K00 phase of the award, Yue will develop genetic engineering approaches to experimentally map higher-order genetic interactions in cancer cells based on the mechanistic insights obtained from VNN during genotype-phenotype prediction. The data generated experimentally can directly inspire targeted treatment designs. In addition, the new data can be integrated into the hierarchical cancer cell map to improve accuracy and resolution of the inferred pathways, thus further improving the “visibility” of VNN in genotype-phenotype prediction. The combination of a computational focused training during F99 phase and experimental focused training during K00 phase will fully prepare Yue leading her own interdisciplinary research in cancer biology. In addition, the personalized training plan covering aspects including mentoring and teaching, scientific writing, and oral presentation will ensure Yue acquiring skills necessary for her future establishment as an independent investigator.

项目总结/文摘